Studying cognition by averaging data from many people's brain scans hides how individuals use their brains, new Stanford ...

Cognitive control is the set of executive functions that underpins our ability to regulate thoughts and actions in line with internal goals, particularly in complex and dynamic environments. Task ...

Cognition–movement coupling is an essential domain within cognitive neuroscience and movement science, examining how thought processes integrate with ...

Research shows that averaging brain scans hides how individuals use their brains, offering new insights into personalized ...

Cognitive control and priming mechanisms lie at the heart of human behavioural regulation. Research in this domain elucidates how the brain flexibly integrates sensory inputs with motor responses, ...

Cognitive control plays a central role in mental skills ranging from plain concentration and focus (on your homework, not that text from your BFF) to calming down after you get upset (say, when you ...

Some recent research has focused on how poor cognitive control, mediated by rumination, leads to or sustain depression and anxiety symptoms (e.g., Cohen, Mor, & Henik ...

Cognitive control refers to using our minds to steer our behaviors and experiences towards better outcomes by overriding habits and other automatic tendencies. For example, we can use cognitive ...

Internationally recognized neuroscientist Ilya Monosov has dedicated his career to understanding how the brain produces and regulates functions such as decision-making, learning, curiosity, ...

Objectives To evaluate the association between cardiorespiratory fitness (CRF) and cognition in a large sample of older adults, and to examine clinical and demographic factors that might moderate ...

Scattered plots are the effect size as a function of age, with curves fitted by GAM (blue color) and the square root model (red color). Shaded areas around the curves represent standard errors. Dashed ...

Most people recognize Alzheimer's from its devastating symptoms such as memory loss, while new drugs target pathological aspects of disease manifestations, such as plaques of amyloid proteins. Now a ...